BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11154228)

  • 1. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription.
    Stein H; Marafioti T; Foss HD; Laumen H; Hummel M; Anagnostopoulos I; Wirth T; Demel G; Falini B
    Blood; 2001 Jan; 97(2):496-501. PubMed ID: 11154228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease.
    Jundt F; Kley K; Anagnostopoulos I; Schulze Pröbsting K; Greiner A; Mathas S; Scheidereit C; Wirth T; Stein H; Dörken B
    Blood; 2002 Apr; 99(8):3060-2. PubMed ID: 11929801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells.
    Theil J; Laumen H; Marafioti T; Hummel M; Lenz G; Wirth T; Stein H
    Blood; 2001 May; 97(10):3191-6. PubMed ID: 11342448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression.
    Ushmorov A; Ritz O; Hummel M; Leithäuser F; Möller P; Stein H; Wirth T
    Blood; 2004 Nov; 104(10):3326-34. PubMed ID: 15284123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.
    Sáez AI; Artiga MJ; Sánchez-Beato M; Sánchez-Verde L; García JF; Camacho FI; Franco R; Piris MA
    Mod Pathol; 2002 Mar; 15(3):211-20. PubMed ID: 11904338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the aldehyde dehydrogenase 2-like gene is controlled by BOB.1/OBF.1 in B lymphocytes.
    Brunner C; Laumen H; Nielsen PJ; Kraut N; Wirth T
    J Biol Chem; 2003 Nov; 278(46):45231-9. PubMed ID: 12947107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.
    Re D; Müschen M; Ahmadi T; Wickenhauser C; Staratschek-Jox A; Holtick U; Diehl V; Wolf J
    Cancer Res; 2001 Mar; 61(5):2080-4. PubMed ID: 11280769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1.
    Pfisterer P; Zwilling S; Hess J; Wirth T
    J Biol Chem; 1995 Dec; 270(50):29870-80. PubMed ID: 8530384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BOB.1 / OBF.1 co-activator is essential for octamer-dependent transcription in B cells.
    Laumen H; Nielsen PJ; Wirth T
    Eur J Immunol; 2000 Feb; 30(2):458-69. PubMed ID: 10671201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octamer-dependent transcription in T cells is mediated by NFAT and NF-κB.
    Mueller K; Quandt J; Marienfeld RB; Weihrich P; Fiedler K; Claussnitzer M; Laumen H; Vaeth M; Berberich-Siebelt F; Serfling E; Wirth T; Brunner C
    Nucleic Acids Res; 2013 Feb; 41(4):2138-54. PubMed ID: 23293002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma.
    García-Cosío M; Santón A; Martín P; Camarasa N; Montalbán C; García JF; Bellas C
    Mod Pathol; 2004 Dec; 17(12):1531-8. PubMed ID: 15257313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma.
    Herbeck R; Teodorescu Brînzeu D; Giubelan M; Lazăr E; Dema A; Ioniţă H
    Rom J Morphol Embryol; 2011; 52(1):69-74. PubMed ID: 21424034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Btk expression is controlled by Oct and BOB.1/OBF.1.
    Brunner C; Wirth T
    Nucleic Acids Res; 2006; 34(6):1807-15. PubMed ID: 16582106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.
    Torlakovic E; Tierens A; Dang HD; Delabie J
    Am J Pathol; 2001 Nov; 159(5):1807-14. PubMed ID: 11696441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma.
    Ushmorov A; Leithäuser F; Sakk O; Weinhaüsel A; Popov SW; Möller P; Wirth T
    Blood; 2006 Mar; 107(6):2493-500. PubMed ID: 16304050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas.
    Greiner A; Müller KB; Hess J; Pfeffer K; Müller-Hermelink HK; Wirth T
    Am J Pathol; 2000 Feb; 156(2):501-7. PubMed ID: 10666379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myosin light chain 1 atrial isoform (MLC1A) is expressed in pre-B cells under control of the BOB.1/OBF.1 coactivator.
    Laumen H; Brunner C; Greiner A; Wirth T
    Nucleic Acids Res; 2004; 32(4):1577-83. PubMed ID: 15004244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development.
    Hess J; Nielsen PJ; Fischer KD; Bujard H; Wirth T
    Mol Cell Biol; 2001 Mar; 21(5):1531-9. PubMed ID: 11238890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB-dependent signals control BOB.1/OBF.1 and Oct2 transcriptional activity in B cells.
    Kilzheimer M; Quandt J; Langhans J; Weihrich P; Wirth T; Brunner C
    Eur J Immunol; 2015 Dec; 45(12):3441-53. PubMed ID: 26361887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.